Gilead Sciences, Inc.
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Arcus Biosciences — Operating income (loss) by Year
Arcus Biosciences — Operating income (loss) ($M) ($M)
Gilead Sciences Arcus Biosciences — Operating income (loss): -$386M in FY2025, up 17.0% from a year earlier.
Where the FY2025 figure comes from
Source: Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗
Reported in Arcus Biosciences (RCUS) Form 10-Q / 10-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Arcus Biosciences — Operating income (loss) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -386 | +17.0% | Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗ |
| FY2024 | Dec 31, 2024 | -330 | -2.9% | Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗ |
| FY2023 | Dec 31, 2023 | -340 | +21.4% | Arcus Biosciences (RCUS) Form 10-K (filed 2026-02-25) ↗ |
| FY2022 | Dec 31, 2022 | -280 | -618.5% | Arcus Biosciences (RCUS) Form 10-K (filed 2025-02-25) ↗ |
| FY2021 | Dec 31, 2021 | 54 | -143.5% | Arcus Biosciences (RCUS) Form 10-K (filed 2024-02-21) ↗ |
| FY2020 | Dec 31, 2020 | -124 | +39.8% | SEC Filing ↗ |
| FY2019 | Dec 31, 2019 | -88.7 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Gilead Sciences Arcus Biosciences — Operating income (loss) ($M), annual FY2019–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rcus-op-inc
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.